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ABSTRACT  
Introduction: Diabetic mellitus is a metabolic disease. Diabetic mellitus also a crhonic disease and have 
a complications. One of the complication is diabetic peripheral neuropathy. 60-70% patient with diabetic 
mellitus also has diabetic peripheral neuropathy. Factors that contribute of diabetic peripheral 
neuropathy incident are length of diabetes, ages, and poor of glucose control. This study aims to knew 
correlate beetwen length of diabetes with diabetic peripheral neuropathy incident. Method: This study 
used cross sectional design with 79 respondents and recruited by simple random sampling methode. 
Data were collected from patients with diabetic mellitus. Diabetic peripheral neuropathy was measured 
by diabetic neuropathy symptom (DNS). Results: Chi square test analysis showed no significant 
correlate beetwen length of diabetes with diabetic peripheral neuropathy incident (p value > 0.05). 
Discussion: It can be inferred that length of diabetes is not only one risk factors that contributed diabetic 
peripheral neuropathy incident. Therefore, need more reseacrh to correlate beetwen diabetic peripheral 
neuropathy incident with the other factors. 
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INTRODUCTION 
Diabetes mellitus can be defined as a 
disorder of the body mechanism in turning 
glucose into energy that results in high blood 
glucose levels (hyperglycemia) and cause few 
symptoms (Day, 2001). Diabetes mellitus 
which is not well controlled can cause vascular 
complications. Vascular complications are 
divided into macrovascular (coronary heart 
disease, stroke) and microvascular 
(retinopathy, nephropathy, neuropathy) (Black 
& Hawk , 2009). Microvascular complications 
include damage to the eyes (retinopathy ) which 
can lead to blindness , kidney damage ( 
nephropathy ), which ended in kidney failure , 
and damage to the nerves (neuropathy), which 
resulted in the disruption of the diabetic foot up 
the possibility of amputation of the limbs 
(Ignatavicius & Workman, 2010) . 
The incidence of diabetic neuropathy 
occurs between 60% and 70% in patients with 
diabetes mellitus type I and type II in the 
presence of neurological complications 
(Lemone & Burke, 2008). Cohort study on 
4400 patients in Belgium, found that 7.5% of 
respondents had neuropathy in the early 
diagnosis of DM. After 25 years, neuropathy 
increased to 45%. Incidence in the United 
Kingdom, the prevalence of diabetic 
neuropathy in a patient population at the 
hospital were approximately 29% have diabetic 
peripheral neuropathy (Argoff et al., 2006). 
Factors that associated with 
neuropathy, according to Black & Hawks 
(2009) includes vascular insufficiency, chronic 
increase of blood glucose and other metabolic 
factors. Other risk factors that can lead to 
diabetic neuropathy, according Katulanda., Et 
al (2012) include increasing age, duration of 
diabetes mellitus and poor blood sugar control. 
Preliminary studies that conducted at the 
General Hospital of Demak, gave data from 7 
outpatients with DM, 4 (seven) of patients 
experienced symptoms of diabetic neuropathy 
such as numbness in the feet. 
Research on the complications of 
diabetes mellitus were done but research on 
factors that associated with the incidence of 
diabetic peripheral neuropathy has not been 
widely discussed. The purpose of this study is 
to determine the relationship between duration 
of DM with diabetic peripheral neuropathy. 
 
METHOD 
This study was an observational study 
with cross sectional approach. A total of 79 
respondents were used as a sample with a 
sampling technique in the form of simple 
random sampling. Criteria for inclusion of 
samples in this study were all patients with type 
2 diabetes who seek treatment at out patientof 
 
Demak General Hospital. The instrument used 
to evaluate diabetic peripheral neuropathy is 
diabetic neuropathy symptoms (DNS). 
DNS instrument is an instrument used 
to assess the incidence of diabetic peripheral 
neuropathy. DNS total score is 4, if patients 
with DM had a score of 1 is included into 
diabetic peripheral neuropathy (Meijer, J.W.K., 
Bosma, E., Lefrandt, J.D., Links, T.P., Smith, 
A.J., Steward, R.E., 2002). In Indonesia, the 
DNS instruments have been tested on the 
sensitivity and specificity to rate symptoms of 
peripheral neuropathy in diabetic patients with 
diabetes mellitus with the result p value of 
<0.05 (Mardastuti, 2003). This study data 




Table 1. Distribution of respondent according 
to gender at RSUD Demak, 2016 
(n=79) 
Variable-Gender Total Percentage (%) 
Male 33 41.8 
Female 46 59.2 
Total  79                                     100 
 
As illustrated on table 4.1 majority of 
respondent are female (59.2%) 
 
Table 2. Distribution of respondent according 
to age and length of DM at RSUD 
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6,19 
± 3,8 






As shown in table 4.2 according to the 
age mean of the respondent is 53 years old, the 
youngest age is 30 years old and the eldest is 71 
years old. The length of DM mean of the 
respondent is 6 years old, longest of length of 
DM is 16 years old and the shortest length of 






Table 3 Distribution of respondents according 
to the incidence of diabetic peripheral 
neuropathy at RSUD Demak, 2016 
(n=79) 
Variable Total Percentage (%) 
Yes 75 94,9 
No 4 5,1 
Total 79 100 
 
As illustrated in table 4.3, 75 
respondents suffering of diabetic peripheral 
neuropathy. As shown in table 4.3 with Chi 
square test the result found that p value 0.55 (p 
value<0.05) so it can be concluded that there is 
no significant relationship between the length 
of DM and incidence of diabetic peripheral 
neuropathy. 
Table 4. Analysis of correlation between length 
of DM with incidence of diabetic 
peripheral neuropathy at RSUD 
Demak, 2016 (n=79) 









1-6 2 (2,5%) 44 (55,7%) 0,55 
7-16 2 (2,5%) 31 (39,2%)  
Total  4 (5,1%) 75 (94,9%)  
 
DISCUSSION 
The results of data analysis showed 
that female was the most experienced on 
neuropathy. These results are consistent with te 
relevant previous research which states that the 
potential risk factor for diabetic neuropathy is 
greater in women by 78% compared to male 
respondents 22% (Booya et al, 2005). Relevant 
research results on the effect of peripheral 
neuropathy, gender, and obesity on postural 
stability of patients with type 2 diabetes 
mellitus respondents stated that as many as 107 
of the 151 respondents who experienced 
peripheral neuropathy in diabetic are women. 
Another study from Aaberg, L (2007) entitled 
"Gender differences in the onset of diabetic 
neuropathy" indicates that of the total 376 
respondents who experienced peripheral 
neuropathy in diabetic there were 220 
respondents (59%) are women, but the onset 
occurs peripheral neuropathy in diabetic are 
more a lot of men. 
The average of long suffered from 
diabetes is 6 years old. There are 4 respondents 
who had experienced diabetic peripheral 
neuropathy after 1 year of DM. These results 
 
are consistent with other relevant research that 
states that diabetic peripheral neuropathy 
experienced by diabetic patients occurred since 
3-5 years after a diagnosis of DM (Tefaye et al, 
2005). The length of people experience DM in 
line with the DM complications, it is means that 
the longer experienced DM, the higher the 
incidence of complications experienced by 
patients. According to Suzuki, et al (2001) 
stated that the duration of suffering from 
diabetes with hyperglycemia affect changes to 
the walls of blood vessels and blood pressure. 
Blood vessels consist of endothelial 
cells that line the inside lumen of all blood 
vessels and serve as a connection between 
blood circulation and smooth muscle cells of 
blood vessels (Hayat, 2004). Besides acting as 
a physical barrier between blood and tissue, 
endothelial cells facilitated the various complex 
functions of cells and vascular smooth muscle 
cells in the blood compartment (Haller, 1997). 
Relevant results of previous studies stated that 
as a result of chronic hyperglycemic can cause 
endothelial malfunction (De Meyer, 1997). So 
the assumptions of researchers from the 
destruction of endothelial cells will lead to a 
decrease in the function of peripheral nerve 
cells. 
According to Bryan & Nick (2007) 
that the length of time a person suffers from 
diabetes can aggravate the risk of complications 
of diabetes mellitus including the form of 
neuropathy and diabetic ulcers. Similarly, 
according to Loughlin and Artlett (2009) a 
prolonged hyperglycemi can result the 
glycosylation reactionon nonenzimatik mailard 
reaction between the protein and the reactive 
Carbonyl and Dicarbonyl compounds. The 
degradation of protein glycosylation resulted in 
the formation of α-dikarbonyl, 3-
deoxyglucosone (3DG), which would then 
form the advanced glication end products 
(AGEs), and eventually lead to diabetic 
peripheral neuropathy. 
The length of time diagnosed diabetes 
is also associated with a decrease in the 
function of pancreatic beta cells, causing 
complications that commonly occur in patients 
with disease duration 5-10 years (Smeltzer & 
Bare, 2010). This is consistent with the theory 
that a decrease in the function of pancreatic beta 
cells will have an impact on insulin production. 
Decreasing the amount of insulin in the blood 
would reduce glycolysis in cells. As a result, 
glucose is not absorbed by the cells will lead to 
increased accumulation of glucose in the blood 
vessels and make a hyperglycemic condition 
(Guyton, 2007). 
The results of this study showed 
complications have occurred in the time 
duration is relatively short after a diagnosis of 
DM. Assumptions researchers, the long-
suffering DM submitted by respondents do not 
fully illustrate the long respondents had actual 
diabetes. That's because the new respondents 
know the experience of DM after complications 
occur and the health services. Another 
assumption due to the limited number of 
respondents and the research areas that involve 
only one hospital, then it is not able to describe 
the proportion of the majority of the sexes in 
patients with diabetic peripheral neuropathy. 
That caused no relationship between duration 
of DM with the incidence of diabetic peripheral 
neuropathy. 
In this case, the role of nurse as an 
educator and counselorexplain the individuals 
or families about the signs and symptoms of the 
DM. It is expected to the increase in knowledge 
of the individual or the family to the DM will 
also increase the behavior of individuals or 
families, to immediately conduct investigation 
into the health service after feeling signs and 
symptoms. The faster handling of DM is 





Conclusions from this research is 
there is no relationship between the duration of 
DM with the diabetic peripheral neuropathy ( p 
value> 0.05). Most of the respondents suffered 
from diabetes mean that for 6 years with the 
female gender the most experienced DM. 
The results of this study can be used 
as additional information about factors - factors 
that can lead to diabetic peripheral neuropathy 
so that the diabetic patient can minimize risk of 
complications from diabetes. There are still 
many weaknesses of this study are not yet doing 
leg detection of decreased sensation and 
observation of factors - other factors such as 
age and poor blood sugar control, so that in the 
future needs to do more research to see other 
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